Form 6-K NOVO NORDISK A S For: Oct 02

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. ISRG
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Form 6-K NOVO NORDISK A S For: Oct 02

FDA extends review of Novo Nordisk's haemophilia A drug denecimig

October 5, 2026 6:04 AM EDT

Novo Nordisk (NYSE: NVO) said the U.S. Food and Drug Administration has extended its review of denecimig, a treatment for haemophilia A, due to ongoing facility remediation activities at the company's manufacturing site.

Novo Nordisk submitted a Biologics License Application (BLA) for denecimig in September 2025, targeting... More